Avivagen Inc
Description Chemaphor Inc., a development stage company, develops small-molecule compound discoveries for commercialization in biotechnology sectors primarily in Canada, the United States, and Europe. It develops proprietary products for the food animal market, companion animal market, and potential human applications using the oxidation of carotenoids. The company primarily offers Oximunol Chewables, which contains OxC-beta formulated for use in companion dogs to optimize gastrointestinal health. It also provides OxC-beta intended for use as a non-antibiotic and non-hormonal feed additive for livestock. Further, the company owns marketing rights for VetStem RC regenerative cell therapy, which is intended for the treatment of arthritic conditions, and joint and ligament injuries in dogs, cats, and horses in Canada. Additionally, it provides a range of custom made chemicals primarily deuterated compounds, such as vitamin D and its hydroxy metabolites, vitamin E, and cholesterol and its hydroxy metabolites. The company also makes specialty and non-labeled small-molecule compounds for screening as drug candidates. Chemaphor Inc. was founded in 1997 and is headquartered in Ottawa, Canada. To view the detailed information, you need to SUBSCRIBE with us. |
 |